Category:
Active Pharmaceutical Ingredients
CAS NO:
1072833-77-2
Standard:
In-house Standards,
Oncology Myeloma
Ixazomib (MLN2238) is an oral bortezomib-like proteasome inhibitor developed for oncology. Its molecular formula is C19H24ClN5O4 with CAS No. 860667-03-0.
Contraindicated in patients with hypersensitivity to ixazomib or boron. Store below 25°C in dry conditions. Monitor for peripheral neuropathy and thrombocytopenia during therapy.